Employee Severance, Litigation, and Other

3 Months Ended

Dec. 31, 2018

Restructuring and Related Activities [Abstract]

Employee Severance, Litigation, and Other

Employee Severance, Litigation, and Other

The following illustrates the charges incurred by the Company relating to Employee Severance, Litigation, and Other for the periods indicated:

	Three months ended December 31,
(in thousands)	2018		2017
Employee severance	$	3,765	$	7,671
Litigation and opioid-related costs	14,539		2,809
Other	22,368		19,541
Total employee severance, litigation, and other	$	40,672	$	30,021

Employee severance in the three months ended December 31, 2018 included costs primarily related to position eliminations resulting from our business transformation efforts and restructuring activities related to our consulting business. Employee severance in the three months ended December 31, 2017 included costs primarily related to position eliminations resulting from our business transformation efforts.

Litigation and opioid-related costs in the three months ended December 31, 2018 and 2017 primarily related to legal fees in connection with opioid lawsuits and investigations.

Other costs in the three months ended December 31, 2018 included $11.6 million of acquisition-related deal and integration costs, $7.0 million related to the Company's business transformation efforts, and $3.8 million of other restructuring initiatives. Other costs in the three months ended December 31, 2017 included $10.7 million of restructuring initiatives, $4.7 million related to the Company's business transformation efforts, and $4.1 million of acquisition-related deal and integration costs.